The NIH Stroke Scale (NIHSS) is a systematic assessment tool used to quantify the impairment caused by a stroke. It consists of 11 items that measure various aspects of neurological function. Each item is scored individually, and the total score helps determine stroke severity and guide management decisions.
Item | Description | Score Range |
1a. Level of Consciousness | Assesses patient's alertness and responsiveness | 0 (Alert) to 3 (Unresponsive) |
1b. LOC Questions | Asks the patient the month and their age | 0 (Answers both correctly) to 2 (Answers neither correctly) |
1c. LOC Commands | Commands the patient to open and close their eyes and grip and release their hand | 0 (Performs both correctly) to 2 (Performs neither correctly) |
2. Best Gaze | Assesses voluntary eye movements and horizontal gaze | 0 (Normal) to 2 (Forced deviation) |
3. Visual Fields | Tests visual fields in four quadrants by confrontation | 0 (No visual loss) to 3 (Complete hemianopia) |
4. Facial Palsy | Evaluates facial muscle movement in response to commands | 0 (Normal symmetry) to 3 (Complete paralysis) |
5a. Motor Arm (Left) | Tests motor function of the left arm with drift for 10 seconds | 0 (No drift) to 4 (No movement) |
5b. Motor Arm (Right) | Tests motor function of the right arm with drift for 10 seconds | 0 (No drift) to 4 (No movement) |
6a. Motor Leg (Left) | Tests motor function of the left leg with drift for 5 seconds | 0 (No drift) to 4 (No movement) |
6b. Motor Leg (Right) | Tests motor function of the right leg with drift for 5 seconds | 0 (No drift) to 4 (No movement) |
7. Limb Ataxia | Assesses for ataxia with finger-nose and heel-shin tests | 0 (Absent) to 2 (Present in both arms and legs) |
8. Sensory | Evaluates the patient's response to pinprick sensation | 0 (Normal) to 2 (Complete sensory loss) |
9. Best Language | Assesses the patient’s ability to describe a picture, name objects, and read sentences | 0 (No aphasia) to 3 (Mute, global aphasia) |
10. Dysarthria | Evaluates the clarity of the patient's speech | 0 (Normal) to 2 (Unintelligible or mute) |
11. Extinction and Inattention | Tests for neglect with tasks assessing extinction and inattention (tactile, visual, auditory) | 0 (No neglect) to 2 (Profound neglect in >1 modality) |
Total Score: The total NIHSS score ranges from 0 to 42, where higher scores indicate more severe stroke-related neurological deficits.
The ABCD2 score is a clinical tool used to predict the short-term risk of stroke following a transient ischemic attack (TIA). It evaluates five clinical parameters, with a maximum score of 7.
Factor | Criteria | Points |
A: Age | ≥ 60 years | 1 |
B: Blood Pressure | Systolic ≥ 140 mmHg or Diastolic ≥ 90 mmHg | 1 |
C: Clinical Features | Unilateral weakness | 2 |
Speech disturbance without weakness | 1 | |
Other clinical features | 0 | |
D: Duration of Symptoms | ≥ 60 minutes | 2 |
10-59 minutes | 1 | |
< 10 minutes | 0 | |
D: Diabetes | Presence of diabetes | 1 |
Total Score: The total ABCD2 score ranges from 0 to 7, with higher scores indicating a greater risk of stroke within 2 days of the TIA.
Detailed Discussion on NIHSS and ABCD2 Score
NIH Stroke Scale (NIHSS):
What It Is:
The NIH Stroke Scale is a comprehensive, standardized tool designed to assess the neurological status of stroke patients. It evaluates consciousness, language, motor function, sensory function, and coordination among other parameters.
Why We Use It:
Stroke Severity: The NIHSS provides a quantifiable measure of stroke severity, which helps in determining the appropriate level of care, need for interventions like thrombolysis, and predicting patient outcomes.
Treatment Decision-Making: A higher NIHSS score often indicates a need for more aggressive treatment, such as thrombolytic therapy or mechanical thrombectomy in acute ischemic stroke.
Monitoring Progress: Regular use of NIHSS can help track the progression or improvement of neurological deficits over time, aiding in treatment adjustments and prognostic discussions.
How We Use It:
Initial Assessment: The NIHSS is used at the initial presentation of a patient with suspected stroke to establish a baseline for neurological function.
Reassessment: It is also used during subsequent assessments to monitor changes in the patient’s neurological status, particularly after interventions or as part of ongoing management.
Training and Standardization: Clinicians are trained to use the NIHSS consistently to reduce variability in scoring, ensuring accurate and reliable assessments across different healthcare providers.
How Important It Is:
Clinical Relevance: NIHSS scores are strongly correlated with outcomes after stroke. Higher scores are associated with greater initial stroke severity, increased risk of complications, and worse functional outcomes.
Guideline Integration: The NIHSS is integrated into various clinical guidelines for stroke management, including recommendations for thrombolytic therapy, which often uses a cutoff score to determine eligibility.
ABCD2 Score:
What It Is:
The ABCD2 score is a clinical prediction tool that estimates the risk of stroke in patients who have experienced a transient ischemic attack (TIA). It combines five factors to stratify patients into low, moderate, or high risk of subsequent stroke.
Why We Use It:
Stroke Risk Stratification: The score helps clinicians quickly identify patients at high risk of stroke within 2 days of a TIA, allowing for timely intervention and management.
Resource Allocation: By stratifying patients based on stroke risk, the ABCD2 score aids in deciding which patients require urgent evaluation and which may be safely monitored in an outpatient setting.
Preventive Measures: Identifying high-risk patients facilitates early implementation of secondary prevention strategies, such as antiplatelet therapy, anticoagulation, or lifestyle modifications, to prevent future strokes.
How We Use It:
Initial TIA Assessment: The ABCD2 score is used during the initial evaluation of patients who present with symptoms of a TIA to determine their risk of stroke in the near term.
Guiding Treatment: Patients with higher scores (≥4) are often admitted for observation, further diagnostic evaluation, and initiation of preventive therapies.
Follow-Up Planning: The score helps guide the intensity and frequency of follow-up care needed for patients after a TIA, focusing on those at higher risk for closer monitoring and more aggressive intervention.
How Important It Is:
Predictive Value: The ABCD2 score has been validated in multiple studies as an effective tool for predicting short-term stroke risk following a TIA, with higher scores correlating with higher risks of early stroke.
Clinical Decision-Making: It is a critical tool in emergency and primary care settings, facilitating rapid decision-making regarding the need for hospital admission, further diagnostic testing, and immediate management strategies.
Conclusion
Both the NIH Stroke Scale (NIHSS) and the ABCD2 score are essential tools in the management of stroke and TIA, respectively. The NIHSS helps assess stroke severity, guide treatment decisions, and predict outcomes, while the ABCD2 score identifies patients at high risk for stroke following a TIA and informs the need for urgent intervention. Together, these tools improve patient outcomes through prompt recognition, risk stratification, and tailored management strategies.
Comments